We report the case of a 20-year-old woman with hypertrophic cardiomyopathy and severe brain dysfunction caused by post-resuscitation encephalopathy. Transferred to our hospital's convalescent rehabilitation ward, she aimed to regain independence in daily living and return to college. Upon admission, she was diagnosed with moderate attention impairment and intellectual disability. She underwent a 4-month intensive inpatient rehabilitation program, including occupational therapy (OT). Despite modest improvements in day-to-day activities and brain function by discharge, these were insufficient for her to resume university childcare classes. Further improvement in behavioral control, physical activity management, and exercise tolerance was necessary post-discharge.OT is pivotal in supporting patient self-management of day-to-day activities, is included within the cardiac rehabilitation (CR) program covered by health insurance. Thus, we introduced her to the CR program for aerobic exercise training and OT. Counseling for physical activity based on the aerobic threshold was performed at each visit, using a chart to record daily activities and heart rate to prevent overactivity, which could lead to fatal arrhythmia.Eventually, she resumed her classes and engaged in childcare training. For patients with brain and heart conditions, a combination of rehabilitation in the convalescent ward and outpatient CR seems to be beneficial for secondary prevention and long-term self-management.

Objective：To investigate the purposes, reasons, and issues of Real World Data (RWD) utilization by data source among pharmaceutical companies in Japan. In this study, we focus on RWDs such as Electronic Medical Records (EMR), Personal Health Records, and registries, which are expected to be utilized in the future. Design：Web based-questionnaire surveyMethods：This questionnaire survey was conducted on 68 companies affiliated with Clinical Evaluation Expert Committee in Japan Pharmaceutical Manufacturers Association from January 18th to February 14th in 2022. In principle, the survey covered four divisions (Clinical development, Pharmacovigilance, Medical Affairs, Health Economics & Outcomes Research) of each company, and other cross-functional divisions were also acceptable to answer. Results：［Background］ Of 40 companies out of 68 companies, 102 respondents were responded to this survey. Overall, 75 respondents (73.5％) have “experienced in utilization of RWD”, and 12 (11.8％) have “experienced in considering utilization of RWD”. ［Utilization by RWD Type］ By data source, hospital-based claim data was the most frequently used (65 cases, 63.7％), followed by insurance-based claim data (61 cases, 59.8％), surveys (38 cases, 37.3％), and EMR (36 cases, 35.3％) in experienced RWD utilization. Conclusion：This study revealed the current status and issues related to the utilization of each type of RWDs in Japan. It is expected that data linkage among multiple RWDs and data standardization enable further utilization of RWDs in future.

Objective：To investigate the purposes, reasons, and issues of Real World Data (RWD) utilization by data source among pharmaceutical companies in Japan. In this study, we focus on RWDs such as Electronic Medical Records (EMR), Personal Health Records, and registries, which are expected to be utilized in the future. Design：Web based-questionnaire surveyMethods：This questionnaire survey was conducted on 68 companies affiliated with Clinical Evaluation Expert Committee in Japan Pharmaceutical Manufacturers Association from January 18th to February 14th in 2022. In principle, the survey covered four divisions (Clinical development, Pharmacovigilance, Medical Affairs, Health Economics & Outcomes Research) of each company, and other cross-functional divisions were also acceptable to answer. Results：［Background］ Of 40 companies out of 68 companies, 102 respondents were responded to this survey. Overall, 75 respondents (73.5％) have “experienced in utilization of RWD”, and 12 (11.8％) have “experienced in considering utilization of RWD”. ［Utilization by RWD Type］ By data source, hospital-based claim data was the most frequently used (65 cases, 63.7％), followed by insurance-based claim data (61 cases, 59.8％), surveys (38 cases, 37.3％), and EMR (36 cases, 35.3％) in experienced RWD utilization. Conclusion：This study revealed the current status and issues related to the utilization of each type of RWDs in Japan. It is expected that data linkage among multiple RWDs and data standardization enable further utilization of RWDs in future.

We report the case of a 20-year-old woman with hypertrophic cardiomyopathy and severe brain dysfunction caused by post-resuscitation encephalopathy. Transferred to our hospital's convalescent rehabilitation ward, she aimed to regain independence in daily living and return to college. Upon admission, she was diagnosed with moderate attention impairment and intellectual disability. She underwent a 4-month intensive inpatient rehabilitation program, including occupational therapy (OT). Despite modest improvements in day-to-day activities and brain function by discharge, these were insufficient for her to resume university childcare classes. Further improvement in behavioral control, physical activity management, and exercise tolerance was necessary post-discharge.OT is pivotal in supporting patient self-management of day-to-day activities, is included within the cardiac rehabilitation (CR) program covered by health insurance. Thus, we introduced her to the CR program for aerobic exercise training and OT. Counseling for physical activity based on the aerobic threshold was performed at each visit, using a chart to record daily activities and heart rate to prevent overactivity, which could lead to fatal arrhythmia.Eventually, she resumed her classes and engaged in childcare training. For patients with brain and heart conditions, a combination of rehabilitation in the convalescent ward and outpatient CR seems to be beneficial for secondary prevention and long-term self-management.